Clinical trial
Intensity Modulated Radiotherapy Plus Cisplatin Versus Intensity Modulated Radiotherapy in Patients With Stage 2 Nasopharyngeal Carcinoma: A Phase 3 Multicenter, Open-label, Randomized, Non-inferior Clinical Trial
NCT03068936 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intensity Modulated Radiotherapy Plus Cisplatin Versus Intensity Modulated Radiotherapy in Patients With Stage 2 Nasopharyngeal Carcinoma: A Phase 3 Multicenter, Open-label, Randomized, Non-inferior Clinical Trial
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- March 31, 2017
- Completion date
- September 30, 2021
- Enrollment
- 716 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.